Twist Bioscience (TWST) Gross Profit (2017 - 2026)

Twist Bioscience (TWST) has reported Gross Profit for 10 consecutive years, with $57.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Gross Profit rose 24.1% year-over-year to $57.1 million; the TTM figure through Mar 2026 stood at $213.2 million (up 31.32% YoY), while the FY2025 annual figure was $191.0 million, up 43.23% from the prior year.
• Gross Profit improved to $57.1 million in Q1 2026 per TWST's latest filing, from $54.0 million in the prior quarter.
• Across five years, Gross Profit topped out at $57.1 million in Q1 2026 and bottomed at $18.4 million in Q1 2022.
• Historically, Gross Profit has averaged $35.0 million across 5 years, with a median of $30.9 million in 2024.
• Annual changes were most pronounced in 2022 — Gross Profit jumped 78.48% — and 2023, when it retreated 12.9%.
• Twist Bioscience's Gross Profit stood at $24.8 million in 2022, then gained by 16.78% to $29.0 million in 2023, then jumped by 47.92% to $42.8 million in 2024, then rose by 25.99% to $54.0 million in 2025, then climbed by 5.84% to $57.1 million in 2026.
• Business Quant data shows TWST's Gross Profit at $57.1 million in Q1 2026, $54.0 million in Q4 2025, and $50.8 million in Q3 2025.